•  
    • Home
    • Activities
    • Rare diseases
    • Registries
    • CAHTA
    • MC RareDis
    • Newsletter
    • About us
  •  

    Page 1 of 3212345...Last »

    Online resources for mesothelioma patients

    Tuesday 17 March 2015 | 177 views
    mesoth

    Mesothelioma Help Now is a website providing information, support and resources for patients and their caregivers. It is educating patients and families about mesothelioma, a ->>>

    100 000 Genomes Project in England aims to create treatment for rare disease patients

    Wednesday 11 February 2015 | 367 views
    genome

    A new company owned by the Department of Health England will sequence 100,000 whole genomes from English healthcare system patients by 2017. 100 000 Genomes ->>>

    Ketoconazole HRA® – New Yet Old Orphan Drug for Cushing’s Syndrome Approved

    Thursday 5 February 2015 | 249 views
    drugs

    In November 2014 European Commission granted European marketing authorisation for Ketoconazole HRA® as an orphan drug for the treatment of Endogenous Cushing’s Syndrome. Ketoconazole-containing medicines ->>>

    Autism Spectrum Disorders in Europe project is starting

    Thursday 29 January 2015 | 267 views
    autism

    Understanding about autism will get a boost as universities, charities and expert institutions from 14 European countries come together in a major new programme. Autism Spectrum Disorders in Europe(ASDEU) has been funded by the European Commissionto research autism diagnosis, prevalence and interventions and to improve care and support for peoplewith autism. Autism Spectrum Disorders in Europe (ASDEU) is a three-year programme run by a consortium of 20 groups from 14 countries.  ASDEU has received 2.1 million euros from the Directorate-General of Health and Consumers of theEuropean Commission (DG-SANCO) to increase understanding of and improve responses to autism. BAPES is a member of the programme consortium. The project will ->>>

    What drives the patients to choose cross border healthcare

    Friday 23 January 2015 | 207 views
    crossborder

    The Executive Agency for Consumers, Health and Food (CHAFEA) of the European Commission performed a study into the impact of information on patients’ choice in ->>>


    Page 1 of 3212345...Last »

    
    Copyright © 2015 | ICRDOD - Bulgaria | Term of service | Privacy policy | Advertising policy | RSS Feed